BOOK
Allergy Primer for Primary Care, An Issue of Primary Care: Clinics in Office Practice, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Primary Care: Clinics in Office Practice, guest edited by Dr. Michael Malone, is devoted to Allergy Primer for Primary Care. Articles in this issue include: Indoor and Outdoor Allergies; Food Allergies; Insect Allergy; Drug Allergy; Allergic Dermatoses; Allergic Rhinitis; Respiratory Allergic Disorders; Eosinophilic Gastrointestinal Disorders; Mastocytosis; Allergy Testing; Allergy Immunotherapy; Anaphylaxis; and Complementary and Alternative Treatment for Allergic Conditions.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Allergy Primer for Primary Care\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Foreword: “Lifesavers”\r | vii | ||
| Preface: Allergy Primer for Primary Care\r | vii | ||
| Allergy Testing\r | vii | ||
| Food Allergies\r | vii | ||
| Drug Allergy\r | vii | ||
| Respiratory Allergic Disorders\r | viii | ||
| Insect Allergy\r | viii | ||
| Allergic Dermatoses\r | viii | ||
| Indoor and Outdoor Allergies\r | viii | ||
| Allergic Rhinitis\r | ix | ||
| Anaphylaxis\r | ix | ||
| Allergen Immunotherapy\r | ix | ||
| Eosinophilic Disorders of the Gastrointestinal Tract\r | ix | ||
| Mastocytosis\r | x | ||
| Complementary and Alternative Treatment for Allergic Conditions\r | x | ||
| PRIMARY CARE:\rCLINICS IN OFFICE PRACTICE\rFORTHCOMING ISSUES\r | xi | ||
| FORTHCOMING ISSUES | xi | ||
| December 2016 | xi | ||
| March 2017 | xi | ||
| June 2017 | xi | ||
| RECENT ISSUES | xi | ||
| June 2016 | xi | ||
| March 2016 | xi | ||
| December 2015 | xi | ||
| Foreword:\r“Lifesavers” | xiii | ||
| Preface:\rAllergy Primer for Primary Care | xv | ||
| Erratum | xvii | ||
| Allergy Testing | 363 | ||
| Key points | 363 | ||
| INTRODUCTION | 363 | ||
| SKIN PRICK TESTING | 363 | ||
| CONTRAINDICATIONS | 364 | ||
| FACTORS THAT AFFECT RESULTS | 365 | ||
| FACTORS THAT AFFECT RESULTS: MEDICATIONS | 365 | ||
| RISKS | 367 | ||
| SKIN PRICK: INTERPRETATION OF RESULTS | 367 | ||
| INTRADERMAL TEST | 367 | ||
| IN VITRO TESTING | 369 | ||
| PATCH TESTING | 369 | ||
| SUMMARY | 370 | ||
| REFERENCES | 372 | ||
| Food Allergies | 375 | ||
| Key points | 375 | ||
| INTRODUCTION | 375 | ||
| What Are Food Allergies? | 375 | ||
| PREVENTION | 376 | ||
| Common Food Allergens | 378 | ||
| FOOD ALLERGY SYMPTOMS | 378 | ||
| SPECIFIC FOOD ALLERGIES | 382 | ||
| Nut Allergies | 382 | ||
| Milk Allergies | 383 | ||
| Risk Reduction Strategies | 384 | ||
| Milk | 384 | ||
| Milk products | 384 | ||
| Risk Reduction Strategies: Egg | 384 | ||
| DIAGNOSIS | 386 | ||
| Food Allergen Challenge Test | 386 | ||
| TREATMENT OF FOOD ALLERGIES | 388 | ||
| Strategies Designed to Alter the Immune Response to Food Allergens | 389 | ||
| REFERENCES | 389 | ||
| Drug Allergy | 393 | ||
| Key points | 393 | ||
| INTRODUCTION/EPIDEMIOLOGY | 393 | ||
| RISK FACTORS | 394 | ||
| BASIC PATHOPHYSIOLOGY | 394 | ||
| MECHANISMS OF DRUG HYPERSENSITIVITY REACTIONS | 395 | ||
| CLINICAL PRESENTATION | 397 | ||
| DIAGNOSIS | 397 | ||
| TREATMENT | 398 | ||
| MANAGEMENT | 398 | ||
| PREVENTION | 400 | ||
| REFERENCES | 400 | ||
| Respiratory Allergic Disorders | 401 | ||
| Key points | 401 | ||
| ALLERGIC ASTHMA | 401 | ||
| Introduction | 401 | ||
| Epidemiology/Pathophysiology | 402 | ||
| Clinical Presentation/Diagnosis | 402 | ||
| Management/Treatment | 403 | ||
| ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | 405 | ||
| Introduction | 405 | ||
| Epidemiology | 405 | ||
| Clinical Presentation | 405 | ||
| Radiographic Features | 406 | ||
| Pulmonary Testing | 406 | ||
| Diagnosis | 406 | ||
| Management/Treatment | 407 | ||
| HYPERSENSITIVITY PNEUMONITIS | 407 | ||
| Introduction | 407 | ||
| Epidemiology | 408 | ||
| Clinical Presentation | 408 | ||
| Classification | 409 | ||
| Diagnosis | 409 | ||
| Diagnostic Criteria | 409 | ||
| Definite hypersensitivity pneumonitis | 410 | ||
| Management | 410 | ||
| Treatment | 410 | ||
| Prognosis | 410 | ||
| REFERENCES | 411 | ||
| Insect Allergy | 417 | ||
| Key points | 417 | ||
| INTRODUCTION | 417 | ||
| BACKGROUND | 417 | ||
| EPIDEMIOLOGY | 418 | ||
| RISK FACTORS | 418 | ||
| CLINICAL PRESENTATION | 418 | ||
| MOSQUITOES | 420 | ||
| TICKS | 420 | ||
| FLIES | 421 | ||
| FLEAS | 421 | ||
| BITING MIDGES | 421 | ||
| BEE AND WASP STINGS | 421 | ||
| DIAGNOSIS | 422 | ||
| MEDICAL HISTORY | 423 | ||
| IDENTIFICATION OF INSECT | 424 | ||
| DIAGNOSTIC TESTS | 425 | ||
| DIFFERENTIAL DIAGNOSIS | 426 | ||
| MANAGEMENT/TREATMENT | 427 | ||
| PREVENTION: VENOM IMMUNOTHERAPY | 427 | ||
| REFERENCES | 429 | ||
| Allergic Dermatoses | 433 | ||
| Key points | 433 | ||
| INTRODUCTION | 433 | ||
| ATOPIC DERMATITIS | 433 | ||
| Background | 433 | ||
| Clinical Symptoms and Signs | 434 | ||
| Diagnosis | 434 | ||
| Treatment | 435 | ||
| Emollients/moisturizers | 437 | ||
| Topical corticosteroids | 437 | ||
| Calcineurin inhibitors | 437 | ||
| Antibiotics | 437 | ||
| Antihistamines | 437 | ||
| Immunosuppressive agents and ultraviolet phototherapy | 437 | ||
| Complementary and alternative treatment | 437 | ||
| Prognosis | 438 | ||
| CONTACT DERMATITIS | 439 | ||
| Background | 439 | ||
| Clinical Symptoms and Signs | 439 | ||
| Diagnosis | 440 | ||
| Treatment | 441 | ||
| Prognosis | 441 | ||
| URTICARIA | 441 | ||
| Background | 441 | ||
| Clinical Symptoms and Signs | 442 | ||
| Diagnosis | 442 | ||
| Treatment | 442 | ||
| Antihistamines | 443 | ||
| Systemic corticosteroids | 443 | ||
| Immune modulators | 443 | ||
| Prognosis | 443 | ||
| ANGIOEDEMA | 443 | ||
| Background | 443 | ||
| Clinical Signs and Symptoms | 444 | ||
| Diagnosis | 444 | ||
| Treatment | 444 | ||
| Prognosis | 445 | ||
| REFERENCES | 445 | ||
| Indoor and Outdoor Allergies | 451 | ||
| Key points | 451 | ||
| INTRODUCTION | 451 | ||
| INDOOR ALLERGIES | 452 | ||
| Mites | 452 | ||
| Animal Allergens | 453 | ||
| Insect Allergens | 453 | ||
| Molds and Fungi | 453 | ||
| Tobacco Smoke | 454 | ||
| Cooking Gas and Nitrogen Dioxide | 454 | ||
| Fragrance and Preservatives | 454 | ||
| Chemical Allergens | 454 | ||
| OUTDOOR ALLERGIES | 455 | ||
| Pollens | 455 | ||
| Thunderstorm Asthma | 455 | ||
| Ragweed | 455 | ||
| Grass | 455 | ||
| Tree Pollen | 456 | ||
| AIR POLLUTANTS | 456 | ||
| Particulate Matter and Pollutants | 456 | ||
| DIAGNOSIS | 457 | ||
| TREATMENT | 457 | ||
| Medication Treatment | 457 | ||
| IMMUNOTHERAPY | 460 | ||
| SUMMARY | 460 | ||
| REFERENCES | 460 | ||
| Allergic Rhinitis | 465 | ||
| Key points | 465 | ||
| INTRODUCTION | 465 | ||
| EPIDEMIOLOGY | 465 | ||
| CLINICAL PRESENTATION | 466 | ||
| DIAGNOSIS | 468 | ||
| MANAGEMENT AND TREATMENT | 469 | ||
| CHRONIC RHINOSINUSITIS AND NASAL POLYPS | 472 | ||
| SUMMARY | 473 | ||
| REFERENCES | 473 | ||
| Anaphylaxis | 477 | ||
| Key points | 477 | ||
| INTRODUCTION | 477 | ||
| PATHOPHYSIOLOGY OVERVIEW | 478 | ||
| RISK FACTORS | 478 | ||
| INCIDENCE AND CAUSATIVE AGENTS | 478 | ||
| CLINICAL PRESENTATION | 479 | ||
| Skin | 479 | ||
| Respiratory | 480 | ||
| Lower Airways | 480 | ||
| Gastrointestinal | 480 | ||
| Cardiovascular | 480 | ||
| Central Nervous System | 480 | ||
| Other | 480 | ||
| DIFFERENTIAL DIAGNOSIS | 481 | ||
| DIAGNOSIS | 481 | ||
| MANAGEMENT AND TREATMENT | 482 | ||
| PREVENTION | 483 | ||
| REFERENCES | 484 | ||
| Allergen Immunotherapy | 487 | ||
| Key points | 487 | ||
| INTRODUCTION | 487 | ||
| DIAGNOSIS | 488 | ||
| TYPES OF IMMUNOTHERAPY | 488 | ||
| PROGNOSIS | 489 | ||
| CLINICAL MANAGEMENT | 490 | ||
| DISEASE COMPLICATIONS | 491 | ||
| SUMMARY | 491 | ||
| REFERENCES | 492 | ||
| Eosinophilic Disorders of the Gastrointestinal Tract | 495 | ||
| Key points | 495 | ||
| EOSINOPHILIC GASTROINTESTINAL DISORDERS | 495 | ||
| EOSINOPHILIC ESOPHAGITIS | 495 | ||
| Introduction | 495 | ||
| Basic Pathophysiology | 496 | ||
| Clinical Presentation | 497 | ||
| Diagnosis | 497 | ||
| Management | 497 | ||
| EOSINOPHILIC GASTROENTERITIS | 498 | ||
| Introduction | 498 | ||
| Basic Pathophysiology | 498 | ||
| Clinical Presentation | 499 | ||
| Diagnosis | 499 | ||
| Management | 500 | ||
| EOSINOPHILIC COLITIS | 501 | ||
| Introduction | 501 | ||
| Basic Pathophysiology | 501 | ||
| Clinical Presentation | 501 | ||
| Diagnosis | 501 | ||
| Management | 502 | ||
| SUMMARY | 502 | ||
| REFERENCES | 502 | ||
| Mastocytosis | 505 | ||
| Key points | 505 | ||
| INTRODUCTION | 505 | ||
| EPIDEMIOLOGY | 506 | ||
| MAST CELL BIOLOGY | 506 | ||
| PATHOPHYSIOLOGY | 507 | ||
| CLINICAL MANIFESTATIONS | 507 | ||
| DIAGNOSIS | 508 | ||
| Overview of Diagnostic Tests | 508 | ||
| Bone marrow biopsy | 508 | ||
| Skin biopsy | 508 | ||
| Total tryptase level | 508 | ||
| Complete blood cell count with differential | 508 | ||
| Blood smear | 508 | ||
| Plasma or urinary histamine level | 509 | ||
| Serum chemistry panel | 509 | ||
| Regular bone densitometry | 509 | ||
| Abdominal ultrasound | 509 | ||
| Diagnosis of Systemic Mastocytosis | 509 | ||
| Major criterion | 509 | ||
| Minor criterion | 509 | ||
| Diagnosis of the different mastocytosis categories | 509 | ||
| Indolent systemic mastocytosis | 509 | ||
| Systemic mastocytosis with associated clonal hematologic non–mast cell lineage disease | 509 | ||
| Agressive systemic mastocytosis | 510 | ||
| Mast cell leukemia | 510 | ||
| Diagnosis of Cutaneous Mastocytosis | 510 | ||
| Other Mastocytosis Diagnostic Categories | 510 | ||
| Mast cell sarcoma | 510 | ||
| Extracutaneous mastocytoma | 510 | ||
| MASTOCYTOSIS TREATMENT | 511 | ||
| Trigger Avoidance | 511 | ||
| Anaphylaxis Treatment | 511 | ||
| SYMPTOM-SPECIFIC TREATMENT | 511 | ||
| Treatment of Gastrointestinal Symptoms | 511 | ||
| Treatment of Musculoskeletal Symptoms: Bone Pain, Osteoporosis, and Fractures | 512 | ||
| Treatment of Depression | 512 | ||
| Treatment of Lung symptoms | 512 | ||
| Treatment of Ascites | 512 | ||
| Associated Cognitive Disorders | 513 | ||
| DIAGNOSIS-SPECIFIC TREATMENT | 513 | ||
| Treatment of Cutaneous Mastocytosis | 513 | ||
| Treatment of Systemic Mastocytosis | 513 | ||
| Treatment of Indolent Systemic Mastocytosis | 514 | ||
| SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED CLONAL HEMATOLOGIC NON–MAST CELL LINEAGE DISEASE | 514 | ||
| Treatment of Agressive Systemic Mastocytosis | 514 | ||
| Mast Cell Leukemia | 515 | ||
| Mast Cell Sarcoma | 515 | ||
| Extracutaneous Mastocytoma | 515 | ||
| REFERENCES | 515 | ||
| Complementary and Alternative Treatment for Allergic Conditions | 519 | ||
| Key points | 519 | ||
| INTRODUCTION | 519 | ||
| Traditional Chinese Medicine Formula for Asthma | 520 | ||
| Traditional Chinese Medicine Formula for Allergic Rhinitis | 521 | ||
| Traditional Chinese Medicine Formula for Atopic Dermatitis | 521 | ||
| Traditional Chinese Medicine Formula for Food Allergy | 521 | ||
| Herbal Therapies for Allergic Rhinitis and Conjunctivitis | 521 | ||
| Other Nasal Sprays, Powders, and Ointments for Allergic Rhinitis | 522 | ||
| Acupuncture for Allergic Rhinitis | 523 | ||
| Homeopathy | 523 | ||
| Miscellaneous Complementary and Alternative Medicine Therapies | 523 | ||
| SUMMARY/DISCUSSION | 524 | ||
| REFERENCES | 524 |